Dr. Peyvand Ashtarani to present poster at London Health Research Day
Monday, March 11, 2013
The Department of Family Medicine wishes to congratulate Dr. Peyvand Ashtarani, set to present his poster "Combination of Framingham risk assessment and Harmonized International Diabetic Federation Criteria tools to assess impact on cardiovascular risk assessment" at London Health Research Day on March 19, 2013.
Presented in partnership by the Lawson Health Research Institute and Schulich School of Medicine & Dentistry, the unique research event showcases the outstanding research from students, trainees and postdoctoral scholars from across the city of London.
Combination of Framingham risk assessment and Harmonized International Diabetic Federation Criteria tools to assess impact on cardiovascular risk assessment
By: Dr. Peyvand Ashtarani, MD, Family Medicine Resident
Date: Dec, 2011 - Aug 2012
Background: The prevalence of metabolic syndrome is 20-25% of the adult population in the world and might be even higher in developed countries. Metabolic syndrome increases the risk of stroke and heart attack three-fold and the risk of diabetes type II five-fold. Metabolic syndrome also increases cardiovascular risk 1.5-2 times. The purpose of this study was to diagnose metabolic syndrome and determine its impact on cardiovascular risk.
Methods: A retrospective chart review of 100 patients' charts at a family medicine centre in London, Canada was completed. Men aged 40-65 and women aged 50-65 with low or moderate cardiovascular risk as diagnosed with Framingham risk assessment tool were included in the study. All patients with high cardiovascular risk were excluded from the study. Participants diagnosed with metabolic syndrome, as determined with International Diabetic Federation criteria, had their Framingham risk scores multiplied by 1.5-2 to account for further cardiovascular risk due to the syndrome.
Results: A chart review of 54 males and 46 females with low and moderate cardiovascular risk were included in the study. Of the 100 participants, 26 were identified with metabolic syndrome. These 26 participants had their Framingham scores multiplied by 1.5-2. It was found that 7 of these 26 patients with low cardiovascular risk based of the Framingham tool moved to moderate risk. Seventeen of these 26 patients with moderate Framingham risk moved to severe cardiovascular risk. The remaining 2 patients diagnosed with metabolic syndrome did not move a risk category after the calculation.
Interpretation: Combining the diagnosis of metabolic syndrome with cardiovascular risk in family practice might increase cardiovascular risk screening sensitivity and might identify more people that are at risk. An earlier identification of populations at risk might help in the management of this disease which is a huge burden on society.
Key words: CVDs (Cardiovascular diseases), CV (Cardiovascular), IDFC (International diabetic federation criteria), Electronic medical record (EMR), TG (Triglyceride), HDL (High density lipoprotein), BP (Blood pressure), FBS (Fasting blood sugar).
If you go:
Date: March 19, 2013
Location: London Convention Centre, London, ON
Time: Plenary Session and Poster Competition: 8:00 a.m. - 4:30 p.m., Wine and Cheese: 4:30 - 5:30 p.m., Dinner and Awards: 5:30 - 7:30 p.m.